ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: B-FABP; BLBP; Brain lipid-binding protein; Brain-type fatty acid-binding protein; Fatty acid-binding protein; Fatty acid-binding protein 7; Mammary-derived growth inhibitor related
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected BLBP/FABP7 in rat brain, human brain, and His-tagged recombinant FABP 2,3,4,7. Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected BLBP/FABP7 in human brain tissue sections.Immunofluorescence Analysis: A 1:100 dilution from a representative lot detected BLBP/FABP7 in human cerebellum tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany